Biologische Heilmittel Heel Gmbh
🇨🇱Chile
- Country
- 🇨🇱Chile
- Ownership
- Subsidiary
- Established
- 1936-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.heel.com
Clinical Trials
18
Active:9
Completed:7
Trial Phases
3 Phases
Phase 1:7
Phase 2:2
Phase 3:4
Drug Approvals
1.4k
CANADA:700
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 70
- Next
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (53.8%)Phase 3
4 (30.8%)Phase 2
2 (15.4%)Evaluation of the Effects of Neurexan® on Short-Term Insomnia, Daytime Performance and Stress Response by Polysomnography (PSG), Electroencephalogram (EEG), Stress Biomarkers and Patient-Reported Outcomes (PROs) An Exploratory, Placebo-Controlled Trial in Short-Term Insomnia Patients
Phase 2
Recruiting
- Conditions
- Short-Term Insomnia
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Biologische Heilmittel Heel GmbH
- Target Recruit Count
- 80
- Registration Number
- 2024-514391-41-00
- Locations
- 🇩🇪
Universitaetsklinikum Jena KöR, Jena, Germany
TRAUMED - a Clinical Trial in Acute Ankle Sprain
Phase 3
Completed
- Conditions
- Ankle Sprain
- Interventions
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Biologische Heilmittel Heel GmbH
- Target Recruit Count
- 809
- Registration Number
- NCT06192420
- Locations
- 🇩🇪
UKSH Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands
- First Posted Date
- 2015-11-11
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Biologische Heilmittel Heel GmbH
- Target Recruit Count
- 53
- Registration Number
- NCT02602275
- Locations
- 🇩🇪
Clinical Affective Neuroimaging Laboratory (CANLAB), Magdeburg, Germany
Study of Intra-articular Injections vs Placebo in Patients With Pain From Osteoarthritis of the Knee
Phase 3
Completed
- Conditions
- Osteoarthritis, Knee
- Interventions
- Drug: PlaceboDrug: Traumeel® / Zeel® Injectable Solution
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2018-04-02
- Lead Sponsor
- Biologische Heilmittel Heel GmbH
- Target Recruit Count
- 287
- Registration Number
- NCT01887678
- Locations
- 🇺🇸
Clinical Research Advantage - Arizona II, Phoenix, Arizona, United States
🇺🇸Tucson Orthopaedic Institute, Tucson, Arizona, United States
🇺🇸Universal BioPharma Research Inc., Dinuba, California, United States
Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects
Phase 1
Completed
- Conditions
- Acute Stress Reaction
- Interventions
- Drug: Neurexan®
- First Posted Date
- 2012-10-11
- Last Posted Date
- 2015-02-11
- Lead Sponsor
- Biologische Heilmittel Heel GmbH
- Target Recruit Count
- 65
- Registration Number
- NCT01703832
- Locations
- 🇩🇪
Institut fur Medizinische Psychologie und Verhaltensimmunbiologie Universitatsklinikum Essen, Essen, Germany
🇩🇪Klinische Psychologie und Psychotherapie, Fachbereich Psychologie, Universität Marburg, Marburg, Germany
- Prev
- 1
- 2
- Next
News
No news found